5-hydroxypropafenone has been researched along with Atrial Fibrillation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, MS; Fan, C; Lau, CP; Tang, MO; White, CM | 1 |
1 other study(ies) available for 5-hydroxypropafenone and Atrial Fibrillation
| Article | Year |
|---|---|
Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; China; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Excitatory Amino Acid Antagonists; Female; Hong Kong; Humans; Male; Middle Aged; Oxidation-Reduction; Propafenone | 2001 |